Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter StudyRyutaro Kakinuma, Kiyoshi Murata, Hironobu Ohmatsu et al.|Journal of Thoracic Oncology|2016Cited by 273
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialKaoru Kubota, Satoshi Kudoh, Hiroshi Sakai et al.|Annals of Oncology|2015Cited by 89
Randomized phase III trial of S-1 plus cisplatin versus docetaxel plus cisplatin for advanced non-small-cell lung cancer (TCOG0701).Nobuyuki Katakami, Akihiko Gemma, Hiroshi Sakai et al.|Journal of Clinical Oncology|2012Cited by 17
Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin in Japanese Patients With Locally Advanced Nonsquamous Non–Small Cell Lung CancerSeiji Niho, Tomohide Tamura, Hiroshi Nokihara et al.|American Journal of Clinical Oncology|2014Cited by 2
Phase I Trial of Combination Chemotherapy of Pemetrexed (PEM) Plus Cisplatin (CDDP) and Concurrent Thoracic Radiotherapy (TRT) Followed by PEM Consolidation Therapy in Patients with Locally Advanced Non-Squamous (NON-SQ) Non-Small-Cell Lung Cancer (NSCLC): Post-Hoc Analysis for Progression-Free Survival (PFS) and Recurrent SitesSeiji Niho, Tomohide Tamura, Hiroshi Nokihara et al.|Annals of Oncology|2012Cited by 0